454 related articles for article (PubMed ID: 30498931)
1. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome.
Rostaminia G; Chang C; Pincus JB; Sand PK; Goldberg RP
Int Urogynecol J; 2019 Oct; 30(10):1735-1745. PubMed ID: 30498931
[TBL] [Abstract][Full Text] [Related]
2. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder.
Iyer S; Laus K; Rugino A; Botros C; Lozo S; Botros SM; Goldberg R; Tomezsko J; Gafni-Kane A; Wroblewski K; Sand P
Int Urogynecol J; 2019 Aug; 30(8):1253-1259. PubMed ID: 30467763
[TBL] [Abstract][Full Text] [Related]
3. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
Martin-Garcia M; Crampton J
Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy.
Pincus J; Rostaminia G; Chang C; Gafni-Kane A; Goldberg RP
Neurourol Urodyn; 2019 Aug; 38(6):1676-1684. PubMed ID: 31107570
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
Salatzki J; Liechti MD; Spanudakis E; Gonzales G; Baldwin J; Haslam C; Pakzad M; Panicker JN
BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
[TBL] [Abstract][Full Text] [Related]
6. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.
Kapur A; Aalami Harandi A; Hartman-Kenzler J; Kim J
Neurourol Urodyn; 2024 Apr; 43(4):959-966. PubMed ID: 38390786
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation.
Del Río-Gonzalez S; Aragon IM; Castillo E; Milla-España F; Galacho A; Machuca J; Lara MF; Herrera-Imbroda B
Urology; 2017 Oct; 108():52-58. PubMed ID: 28687483
[TBL] [Abstract][Full Text] [Related]
8. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
Sonmez R; Yildiz N; Alkan H
Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS
J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
Lashin AM; Eltabey NA; Wadie BS
Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E
Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of idiopathic overactive bladder in women: Transcutaneous tibial nerve stimulation alone versus combined with pelvic floor muscle training].
Baati R; Balhi S; Saadi A; Kraiem R; Kennou B; Ayed H; Chebil M
Prog Urol; 2020 Dec; 30(17):1126-1133. PubMed ID: 32682849
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E
Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.
Musco S; Serati M; Lombardi G; Lumi E; Parisi AI; Del Popolo G; Finazzi Agrò E
J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study.
Scaldazza CV; Morosetti C; Giampieretti R; Lorenzetti R; Baroni M
Int Braz J Urol; 2017; 43(1):121-126. PubMed ID: 28124534
[TBL] [Abstract][Full Text] [Related]
17. Persistence in Percutaneous Tibial Nerve Stimulation Treatment for Overactive Bladder Syndrome is Best Predicted by Patient Global Impression of Improvement Rather Than Symptom-Specific Improvement.
Brandon C; Oh C; Brucker BM; Rosenblum N; Ferrante KL; Smilen SW; Nitti VW; Pape DM
Urology; 2021 Feb; 148():93-99. PubMed ID: 33358753
[TBL] [Abstract][Full Text] [Related]
18. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
Tudor KI; Seth JH; Liechti MD; Ochulor J; Gonzales G; Haslam C; Fox Z; Pakzad M; Panicker JN
Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
[TBL] [Abstract][Full Text] [Related]
19. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
Canbaz Kabay S; Kabay S; Mestan E; Cetiner M; Ayas S; Sevim M; Ozden H; Karaman HO
Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
Preyer O; Umek W; Laml T; Bjelic-Radisic V; Gabriel B; Mittlboeck M; Hanzal E
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
